Results 81 - 90 of 425 : Previous 5 6 7 8 9 10 11 12 13 Next
Is This 14.4% Annualized Return Risk-Free?
A merger arbitrage that looks relatively low-risk.
4-Star Stocks Poised to Pop: GlaxoSmithKline
Market-trouncing returns could be written in these four stars.
Onyx isn't going down without a fight.
These stocks have hit bottom. Are they ready to bounce?
How to Be Bullish Without Being Stupid
These investments have both upside exposure and downside protection.
Insider trading needs to be stopped.
Slimming down in anticipation of L-day.
Johnson & Johnson's Simponi Sticks to the Wall
Johnson & Johnson gets its second-generation TNF-alpha inhibitor past the FDA.
Don't Make This Fatal Fund Mistake
Don't pay for your fund manager's education.
Schering and Merck: A Match Made in Purgatory
Merck needs Schering, and Schering has to sit there and take it.
Results 81 - 90 of 425 : Previous 5 6 7 8 9 10 11 12 13 Next